137 related articles for article (PubMed ID: 3653237)
1. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
Jung M; Perio A; Terranova JP; Worms P; Biziere K
Eur J Pharmacol; 1987 Jul; 139(1):111-6. PubMed ID: 3653237
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor subtypes and sexual behavior in female rats.
Dohanich GP; McMullan DM; Cada DA; Mangum KA
Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
[TBL] [Abstract][Full Text] [Related]
3. Central muscarinic control of the pattern of small intestinal motility in rats.
Fargeas MJ; Fioramonti J; Buéno L
Life Sci; 1987 Apr; 40(17):1709-15. PubMed ID: 3561171
[TBL] [Abstract][Full Text] [Related]
4. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.
Aura J; Sirviö J; Riekkinen P
Eur J Pharmacol; 1997 Aug; 333(2-3):129-34. PubMed ID: 9314025
[TBL] [Abstract][Full Text] [Related]
5. Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine.
Hagan JJ; Jansen JH; Broekkamp CL
Psychopharmacology (Berl); 1987; 93(4):470-6. PubMed ID: 3124181
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.
de Belleroche J; Gardiner IM
Br J Pharmacol; 1985 Oct; 86(2):505-8. PubMed ID: 2864975
[TBL] [Abstract][Full Text] [Related]
9. Central oxotremorine antagonist properties of pirenzepine.
Witkin JM; Alvarado-Garcia R; Perez LA; Witkin KM
Life Sci; 1988; 42(24):2467-73. PubMed ID: 3374266
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of physostigmine in rats.
Tang AH; Franklin SR
Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
Xu M; Mizobe F; Yamamoto T; Kato T
Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
[TBL] [Abstract][Full Text] [Related]
12. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster FP; Heath I; Hendrix JC; Shannon HE
J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
[TBL] [Abstract][Full Text] [Related]
13. Central muscarinic M2 cholinoceptors involved in cholinergic hypertension.
Ozkutlu U; Onat F; Aslan AN; Oktay S
Eur J Pharmacol; 1993 Dec; 250(3):349-54. PubMed ID: 8112394
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors.
Power AE; McIntyre CK; Litmanovich A; McGaugh JL
Behav Pharmacol; 2003 May; 14(3):207-13. PubMed ID: 12799522
[TBL] [Abstract][Full Text] [Related]
15. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
Flynn DD; Mash DC
J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
[TBL] [Abstract][Full Text] [Related]
16. Effect of muscarinic cholinergic drugs on ischemia-induced decreases in glucose uptake and CA1 field potentials in rat hippocampus slices.
Shibata S; Kodama K; Tominaga K; Tanaka T; Watanabe S
Eur J Pharmacol; 1992 Oct; 221(1):113-9. PubMed ID: 1459186
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic receptor agonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse.
Ukai M; Shinkai N; Kameyama T
Gen Pharmacol; 1995 Nov; 26(7):1529-32. PubMed ID: 8690240
[TBL] [Abstract][Full Text] [Related]
19. Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.
Worms P; Gueudet C; Pério A; Soubrié P
Psychopharmacology (Berl); 1989; 98(2):286-8. PubMed ID: 2502800
[TBL] [Abstract][Full Text] [Related]
20. Central muscarinic receptor subtypes and carrageenin-induced paw oedema in rats.
Bhattacharya SK; Sen AP; Das Gupta G; Seth K; Seth PK
Res Exp Med (Berl); 1991; 191(1):65-76. PubMed ID: 1674619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
